Presentation is loading. Please wait.

Presentation is loading. Please wait.

Relationship Between Functional Preservation after Segmentectomy and Volume- Reduction Effects after Lobectomy in Stage I Non-small Cell Lung Cancer Patients.

Published bySimon Berg Modified over 5 years ago

Similar presentations

Presentation on theme: "Relationship Between Functional Preservation after Segmentectomy and Volume- Reduction Effects after Lobectomy in Stage I Non-small Cell Lung Cancer Patients."— Presentation transcript:

1 Relationship Between Functional Preservation after Segmentectomy and Volume- Reduction Effects after Lobectomy in Stage I Non-small Cell Lung Cancer Patients with Emphysema  Kosuke Kashiwabara, MD, Ji-Ichiro Sasaki, MD, Tsuyoshi Mori, MD, Hiroaki Nomori, MD, Kazuhiko Fujii, MD, Hirotsugu Kohrogi, MD  Journal of Thoracic Oncology  Volume 4, Issue 9, Pages (September 2009) DOI: /JTO.0b013e3181ae59e2 Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Postoperative change of the FVC and the FEV1 between the lobectomy group and the segmentectomy group in patients with stage I non-small cell lung cancer with the normal spirometric values. FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; °FVC, postoperative change of the FVC; °FEV1, postoperative change of the FEV1. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e3181ae59e2) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Postoperative change of the FVC and the FEV1 between the lobectomy group and the segmentectomy group in patients with stage I non-small lung cancer with the airflow limitations (the FEV1% <70%). FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; °FVC, postoperative change of the FVC; °FEV1, postoperative change of the FEV1. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e3181ae59e2) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 Correlation between the postoperative change of the FEV1 and the %ppoFEV1. Analysis of a linear correlation was performed with the Pearson’s correlation coefficient test. FEV1, forced expiratory volume in 1 second; %ppoFEV1, ratio of the estimated postoperative FEV1 to the predicted normal value of FEV1. Journal of Thoracic Oncology 2009 4, DOI: ( /JTO.0b013e3181ae59e2) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Relationship Between Functional Preservation after Segmentectomy and Volume- Reduction Effects after Lobectomy in Stage I Non-small Cell Lung Cancer Patients."

Similar presentations

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages 1862-1863.

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.

Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.
A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.
Airway obstruction in never smokers: Results from the Third National Health and Nutrition Examination Survey  Bartolome R. Celli, MD, R.J. Halbert, MD,

Airway obstruction in never smokers: Results from the Third National Health and Nutrition Examination Survey  Bartolome R. Celli, MD, R.J. Halbert, MD,
Brandon Stone, MD, Victor S. Mangona, MD, Matthew D

Brandon Stone, MD, Victor S. Mangona, MD, Matthew D
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,

Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Quantification of emphysema with preoperative computed tomography has stronger association with pulmonary complications than pulmonary function test results.

Quantification of emphysema with preoperative computed tomography has stronger association with pulmonary complications than pulmonary function test results.
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 

One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,
Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.

Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.
Lung Volume Reduction Reoperations

Lung Volume Reduction Reoperations
Brandon Stone, MD, Victor S. Mangona, MD, Matthew D

Brandon Stone, MD, Victor S. Mangona, MD, Matthew D
Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease  Yasuo Sekine, MD, Takekazu.

Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease  Yasuo Sekine, MD, Takekazu.
Vibration response imaging versus perfusion scan in lung cancer surgery evaluation  Nuria Marina, MD, Gema Rodriguez-Trigo, MD, Unai Jimenez, MD, Beatriz.

Vibration response imaging versus perfusion scan in lung cancer surgery evaluation  Nuria Marina, MD, Gema Rodriguez-Trigo, MD, Unai Jimenez, MD, Beatriz.
Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin.

Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin.
A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.
Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months  Arturo Navarro-Martin, MD, Samantha Aso, MD, Jon Cacicedo,

Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months  Arturo Navarro-Martin, MD, Samantha Aso, MD, Jon Cacicedo,
Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study  Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.

Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study  Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.

Similar presentations

Ads by Google